Share Twitter LinkedIn Facebook Email Yasir Khan, MD, UC Irvine Health, outlines how DOACS studies may be practice changing for VTE at the MOASC Spotlight on ASH 2017 meeting.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
